Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of LLY will decline by -7.24% over the next 2 Weeks and hit $867.86 by Thursday, April 16, 2026. In that time frame, LLY's share price is expected to range between $846.45 and $889.01.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Apr 16, 2026 | 870.06 | 894.97 | 920.29 |
| Apr 15, 2026 | 881.33 | 907.14 | 933.50 |
| Apr 14, 2026 | 882.00 | 907.69 | 933.80 |
| Apr 13, 2026 | 894.31 | 919.77 | 942.12 |
| Apr 10, 2026 | 887.39 | 911.85 | 935.81 |
| Apr 9, 2026 | 892.30 | 915.29 | 940.23 |
| Apr 8, 2026 | 902.85 | 927.46 | 952.23 |
| Apr 7, 2026 | 904.06 | 928.01 | 952.89 |
| Apr 6, 2026 | 914.80 | 940.08 | 963.99 |
| Apr 3, 2026 | 908.67 | 932.17 | 955.17 |
LLY shares fell -1.98% in Thursday, April 2, 2026's trading session, dropping from a previous close of $954.52 to move at $935.62. The stock demonstrated notable intraday movement (see LLY's key stats for a full breakdown), fluctuating between $930.02 and $957.69, a +2.97% trading range. While recent weeks have seen some volatility, LLY has managed to secure a +1.97% gain over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 2.73M shares changing hands, 3.54M fewer than the previous session. This amounted to $2.55B in total market activity.
Will LLY Continue Its Downward Trend?
According to analyst ratings and projections for LLY, Eli Lilly and Company shares are anticipated to decrease by -1.67%, potentially reaching $920.29 per share by April 16, 2026. Short-term technical indicators currently suggest a neutral sentiment for LLY. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 11 positive trading days within the past 30 sessions. Based on the LLY stock forecast, now is not the best time to buy LLY stock because its current trading price is +4.54% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on LLY covering social and institutional perspectives.
LLY Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into LLY's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 45.11% to 50.22%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 47.71%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 50.15%, maintains a neutral outlook for the long term. Insights into LLY's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Eli Lilly and Short-Term Forecasts
LLY Forecast For Next 5 Days
Our algorithm anticipates Eli Lilly and (LLY) stock could hit $896.38 by Apr 10, 2026. This represents a -4.19% fall from today's price, following a -3.67% change over the past five days.
LLY Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Eli Lilly and Company (LLY) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $844.64, which would mean a -9.72% decrease from the current price of $935.62. Projections for this period range from a high of $942.52 to a low of $742.91.
LLY Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Eli Lilly and's price over the next three months point to a rise. LLY stock is expected to peak at $1,028.40 on Apr 24, 2026 before potentially dipping to $906.78 on May 12, 2026. On average, LLY is likely to trade around $965.29 in the coming 90 days.
Eli Lilly and Stock Forecast 2025
Based on our predictive models, Eli Lilly and (LLY) is expected to trade between $906.78 and $1,128.64 throughout 2026. This would result in an average price of $1,006.11, potentially offering investors a +7.53% return from current levels.
Eli Lilly and Company Monthly Forecast 2026–2027
April 2026
According to our latest forecast models, Eli Lilly and Company (LLY) is positioned to show a strong performance in April 2026. The price is predicted to move between $916.33 and $1028.40, settling at an average of $972.71. This could translate to a +3.96% gain.
May 2026
Based on current market signals, Eli Lilly and Company is projected to trend may 2026. We forecast a trading range from $906.78 to $1023.74, with a likely average price of $968.16. Investors could expect a potential return of +3.48%.
June 2026
Our predictive algorithms indicate Eli Lilly and Company stock may see a shift in June 2026. The expected range spans $907.51–$1008.89, with an average target of $956.50. This represents a positive outlook and a possible gain of +2.23%.
July 2026
Analyzing established trends, Eli Lilly and Company looks set to move in July 2026. Projections place the stock between $912.57 and $1051.51, averaging around $979.47. This suggests a +4.69% gain from current levels.
August 2026
Market indicators suggest Eli Lilly and Company could experience notable changes during August 2026. Prices could fluctuate within $931.10 to $1061.21, with a midpoint forecast of $984.65. The stock might deliver a +5.24% gain.
September 2026
Forecasting for September 2026, models estimate that Eli Lilly and Company may undergo key fluctuations. If trends hold, the stock might trade between $981.41 and $1101.01, averaging $1047.70. This signals a positive trajectory with potential returns around +11.98%.
October 2026
According to our latest forecast models, Eli Lilly and Company (LLY) is positioned to show a strong performance in October 2026. The price is predicted to move between $986.97 and $1117.66, settling at an average of $1044.69. This could translate to a +11.66% gain.
November 2026
Based on current market signals, Eli Lilly and Company is projected to trend november 2026. We forecast a trading range from $982.79 to $1113.31, with a likely average price of $1035.11. Investors could expect a potential return of +10.63%.
December 2026
Our predictive algorithms indicate Eli Lilly and Company stock may see a shift in December 2026. The expected range spans $988.80–$1128.64, with an average target of $1058.89. This represents a positive outlook and a possible gain of +13.18%.
January 2027
Analyzing established trends, Eli Lilly and Company looks set to move in January 2027. Projections place the stock between $1002.81 and $1138.42, averaging around $1062.99. This suggests a +13.61% gain from current levels.
February 2027
Market indicators suggest Eli Lilly and Company could experience notable changes during February 2027. Prices could fluctuate within $1069.89 to $1180.82, with a midpoint forecast of $1126.35. The stock might deliver a +20.39% gain.
March 2027
Forecasting for March 2027, models estimate that Eli Lilly and Company may undergo key fluctuations. If trends hold, the stock might trade between $1061.49 and $1176.98, averaging $1118.52. This signals a positive trajectory with potential returns around +19.55%.
April 2027
According to our latest forecast models, Eli Lilly and Company (LLY) is positioned to show a strong performance in April 2027. The price is predicted to move between $1059.66 and $1153.43, settling at an average of $1104.37. This could translate to a +18.04% gain.
LLY's history of dividends and stock splits also plays a role in long-term investor confidence.

